APA (7th ed.) Citation

T, S., E, L., N, S., & J, L. (2026). Leveraging real-world data to conduct externally controlled trial for rare diseases with count-type endpoints: Utilizing multiple entries - a simulation study. Journal of biopharmaceutical statistics, 36(3), 337. https://doi.org/10.1080/10543406.2024.2420644

Chicago Style (17th ed.) Citation

T, Sun, Liao E, Shao N, and Luo J. "Leveraging Real-world Data to Conduct Externally Controlled Trial for Rare Diseases with Count-type Endpoints: Utilizing Multiple Entries - a Simulation Study." Journal of Biopharmaceutical Statistics 36, no. 3 (2026): 337. https://doi.org/10.1080/10543406.2024.2420644.

MLA (9th ed.) Citation

T, Sun, et al. "Leveraging Real-world Data to Conduct Externally Controlled Trial for Rare Diseases with Count-type Endpoints: Utilizing Multiple Entries - a Simulation Study." Journal of Biopharmaceutical Statistics, vol. 36, no. 3, 2026, p. 337, https://doi.org/10.1080/10543406.2024.2420644.